Long-Term Care
Chronic therapy administration for populations who may require ongoing care support and experience mobility limitations.
Market Opportunity
The shift toward decentralized subcutaneous drug delivery represents a significant transformation in chronic therapy administration. As care moves from clinical settings into homes, long-term care facilities, and community settings, the need for adaptable wearable infusion solutions grows. Wearable drug delivery systems represent a fast-growing segment within this therapeutic pathway.
A Changing Care Model
As chronic therapy increasingly extends into homes, long-term care facilities and community settings, adaptable delivery approaches become increasingly relevant to how treatment fits into everyday life.
Chronic therapy administration for populations who may require ongoing care support and experience mobility limitations.
Treatment delivered where people live increases the importance of systems that can integrate more naturally into everyday routines.
Community-based treatment environments create opportunities for more adaptable approaches outside centralized clinical infrastructure.
Initial Focus
PRÉVION’s initial market focus is long-term care, where chronic therapy administration may intersect with ongoing support needs, mobility limitations and the realities of everyday care.
Future Categories
As development progresses, PRÉVION is evaluating additional therapeutic and decentralized-care applications for its platform approach.
Future areas of exploration only. These are not current regulatory indications.
Prolonged chemotherapy and supportive care delivery.
Insulin and GLP-1 analogue delivery.
Continuous analgesic infusion.
Parenteral and enteral nutrient delivery.
Temperature-sensitive biologic administration.
Post-exertion recovery and hydration therapies.
Decentralized therapy in low-infrastructure settings.